[Federal Register Volume 63, Number 38 (Thursday, February 26, 1998)] [Notices] [Page 9846] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 98-4869] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following National Cancer Institute Special Emphasis Panel (SEP) meeting: Name of SEP: Polyvalent Vaccine Phase III Trial--Stage VI-- Melanoma. Telephone Conference Call. Date: March 17, 1998. Time: 1 p.m. to Adjournment. Place: National Cancer Institute, Executive Plaza North, Room 611C, 6130 Executive Boulevard, Bethesda, MD 20892-7403. Contact Person: John L. Meyer, Ph.D., Scientific Review Administrator, National Cancer Institute, NIH, Executive Plaza North, Room 611C, 6130 Executive Boulevard, MSC 7403, Bethesda, MD 20892-7403, Telephone: 301/496-7721. Purpose/Agenda: To review, discuss and evaluate grant applications. The meeting will be closed in accordance with the provisions set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications and the discussions could reveal confidential trade secrets or commercial property such as patentable material and personal information concerning individuals associated with the applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. (Catalog of Federal Domestic Assistance Program Numbers: 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control) Dated: February 19, 1998. LaVeen Ponds, Acting Committee Management Officer, National Institutes of Health. [FR Doc. 98-4869 Filed 2-25-98; 8:45 am] BILLING CODE 4140-01-M